The Late Group was administrated at 16 weeks after DEN injection, as expected, seven mice injected with adenovirus for Dlk1 knockdown showed the significant reduction of tumor number, size and weight, as compared to mice injected with control vector (Figure 4D–4F). This evidence concerns the gene DLK1 and neoplasm.